Is it possible to reduce cardiovascular risk with glucose-lowering approaches?

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Diseases

Background:

• Diabetes mellitus is a significant independent risk factor for cardiovascular events.
• The degree of glucose elevation is a key determinant of cardiovascular risk in diabetes.
• Current evidence on glucose lowering in established diabetes shows mixed cardiovascular benefits.

Purpose of the Study:

• To evaluate the cardiovascular benefits of glucose control in recent-onset versus long-duration diabetes mellitus.
• To emphasize the importance of early intervention in managing diabetes and its cardiovascular complications.
• To support therapeutic strategies targeting early hyperglycemia to achieve long-term cardiovascular benefits.

Main Methods:

• Review of clinical trial data on glucose-lowering interventions in diabetes.
• Analysis of cardiovascular outcomes in patients with recent-onset and long-duration diabetes.
• Assessment of the impact of intensive glucose control on diabetes-related complications and mortality.

Main Results:

• Lowering glucose in established, long-duration diabetes has not shown clear cardiovascular benefits and, in some cases, increased mortality.
• In recent-onset diabetes, glucose control benefits eye and kidney disease, which are cardiovascular risk factors.
• Intensive glucose control for 10 years in recent-onset diabetes reduces long-term myocardial infarction and mortality risk.

Conclusions:

• Early and progressive glucose control in diabetes mellitus is crucial for long-term cardiovascular health.
• Therapeutic strategies targeting hyperglycemia early in diabetes course are likely to yield sustained cardiovascular benefits.
• The growing prevalence of diabetes underscores the need for effective early management to prevent cardiovascular complications.